Biotech · Private company

Tandem Diabetes Care, Inc.

Track this companyFree. Adds Tandem Diabetes Care, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials255 recruiting or active

Pipeline programs11From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline11

Automated Insulin Delivery Settings Initialization and Adaptation AlgorithmType 1 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
Control-IQ technology 1.5Type 2 Diabetes Treated With InsulinClinicalTrials.gov · fetched Nov 12, 2026
Control-IQ technology 2.0Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
Control-IQ Technology v1.5Type 1 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
Predictive Low Glucose SuspendDiabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
Standard Therapy plus continuous glucose monitoring (CGM)Type 2 Diabetes Treated With InsulinClinicalTrials.gov · fetched Nov 12, 2026
SteadiSet Extended Wear Infusion SetType1diabetesClinicalTrials.gov · fetched Nov 12, 2026
SteadiSet Infusion SetDiabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
t:slim X2 insulin pump with Control-IQ technology 1.5Type 1 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
t:slim X2 insulin pump with Control-IQ technology 2.0Type 1 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
t:slim X2 insulin pump with Control-IQ+ technology and Dexcom G6 CGMType 2 Diabetes Treated With InsulinClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials25

Insulin Delivery With Self-Adjusting Closed-Loop and Behavioral Glycemic Control Enhanced by PredictionNA · ACTIVE_NOT_RECRUITING · started May 14, 2026ClinicalTrials.gov NCT07507708 · fetched Nov 12, 2026
Effectiveness of Artificial-Intelligence (AI) Bolus Priming Added to an Existing Fully Automated Control Algorithm (AIDANET)NA · NOT_YET_RECRUITING · started May 1, 2026ClinicalTrials.gov NCT07517770 · fetched Nov 12, 2026
Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 DiabetesNA · COMPLETED · started Feb 18, 2026ClinicalTrials.gov NCT07325461 · fetched Nov 12, 2026
A Randomized Parallel Clinical Trial of AIDANET, an Automated Insulin Delivery Algorithm, in Fully Closed-Loop Vs Hybrid Closed-Loop Mode In Adults With Type 1 Diabetes (AIDANET At Home)NA · ACTIVE_NOT_RECRUITING · started Sep 2, 2025ClinicalTrials.gov NCT07039617 · fetched Nov 12, 2026
AIDANET PediatricsNA · ACTIVE_NOT_RECRUITING · started Jul 21, 2025ClinicalTrials.gov NCT07020936 · fetched Nov 12, 2026
Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin DeliveryNA · RECRUITING · started Jun 5, 2025ClinicalTrials.gov NCT06880835 · fetched Nov 12, 2026
PS230005 Control-IQ 1.5 Post-Approval StudyCOMPLETED · started Jan 30, 2025ClinicalTrials.gov NCT06717451 · fetched Nov 12, 2026
Safety and Feasibility Testing of a Smaller Network Version of AIDANETNA · COMPLETED · started Nov 20, 2024ClinicalTrials.gov NCT06633965 · fetched Nov 12, 2026
Investigational Extended Wear Insulin Infusion Set in People With Type 1 DiabetesNA · COMPLETED · started Mar 7, 2024ClinicalTrials.gov NCT06273124 · fetched Nov 12, 2026
A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 DiabetesNA · COMPLETED · started Jun 1, 2023ClinicalTrials.gov NCT05785832 · fetched Nov 12, 2026
Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 DiabetesNA · COMPLETED · started Feb 1, 2023ClinicalTrials.gov NCT05683392 · fetched Nov 12, 2026
Adaptive Biobehavioral Control (ABC) in a Closed-Loop SystemNA · COMPLETED · started Jan 18, 2023ClinicalTrials.gov NCT05610111 · fetched Nov 12, 2026
Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 DiabetesNA · COMPLETED · started Aug 31, 2022ClinicalTrials.gov NCT05403502 · fetched Nov 12, 2026
Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ)NA · COMPLETED · started Jun 29, 2022ClinicalTrials.gov NCT05422053 · fetched Nov 12, 2026
HCL Single Arm Pilot Study in Treatment of Hyperglycemia of Pediatric ALLEARLY_PHASE1 · TERMINATED · started May 12, 2022ClinicalTrials.gov NCT05006040 · fetched Nov 12, 2026
Adaptation of Insulin Delivery Settings to Improve Clinical Outcomes With AID UseNA · COMPLETED · started Mar 24, 2022ClinicalTrials.gov NCT05204134 · fetched Nov 12, 2026
Control-IQ Technology in Individuals With Type 2 DiabetesNA · COMPLETED · started Nov 30, 2021ClinicalTrials.gov NCT05111301 · fetched Nov 12, 2026
Control-IQ Technology 2.0 Adult and Adolescent Feasibility StudyNA · COMPLETED · started Aug 19, 2021ClinicalTrials.gov NCT05014789 · fetched Nov 12, 2026
Artificial Pancreas - Adolescent Physiology & Psychology Longitudinal EvaluationNA · COMPLETED · started Nov 19, 2020ClinicalTrials.gov NCT04510506 · fetched Nov 12, 2026
Web-Based Simulation Tool For Self-Management Support In Type 1 Diabetes MellitusNA · COMPLETED · started Oct 12, 2020ClinicalTrials.gov NCT04439903 · fetched Nov 12, 2026
Automated Insulin Delivery in Elderly With Type 1 Diabetes (AIDE T1D)PHASE4 · COMPLETED · started Sep 28, 2020ClinicalTrials.gov NCT04016662 · fetched Nov 12, 2026
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 DiabetesPHASE3 · COMPLETED · started Jul 9, 2020ClinicalTrials.gov NCT04233034 · fetched Nov 12, 2026
Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Using Total Daily InsulinNA · COMPLETED · started Jan 15, 2019ClinicalTrials.gov NCT03804983 · fetched Nov 12, 2026
Artificial Pancreas and Remote Monitoring During a T1DM Youth Ski CampNA · COMPLETED · started Dec 18, 2017ClinicalTrials.gov NCT03369067 · fetched Nov 12, 2026
Diabetes Pump With Predictive Low Glucose Suspend Pivotal TrialNA · COMPLETED · started Aug 11, 2017ClinicalTrials.gov NCT03195140 · fetched Nov 12, 2026